<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3190596&amp;fmt=gif">

Thyme Care Named to the 2023 CB Insights’ Digital Health 50 List


Value-based cancer care partner recognized for achievements in care management & coordination 

NEW YORK, December 5, 2023 - CB Insights today named Thyme Care to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023. Recognized as a leader in care management & coordination, Thyme Care is transforming the cancer care experience by improving experience, access, and outcomes, while reducing the total cost of care. 

“The only way to solve the fragmentation in cancer care today is by flipping the status quo on its head. We’re driving a new era of value-based cancer care, through deep collaboration with oncologists, risk-bearing providers, and health plans, that streamlines a complex care journey and ensures everyone has the right information, at the right time, to make informed decisions about their care. It’s an honor to be the only oncology care management company on this year’s CB Insights Digital Health 50 list, and to be named among so many other industry trailblazers pushing the boundaries of what is possible in the world of health technology,” said Robin Shah, ceo & co-founder of Thyme Care. 

Built by oncology industry veterans, Thyme Care deeply understands the needs of oncology patients and the preventable barriers to care that many experience. Thyme Care’s model combines advanced technology with high-touch patient care to support the lifecycle of a member’s cancer journey in and out of the clinic and unify the oncology ecosystem. Powered by a technology-enabled team of nurse practitioners, oncology nurses, and resource specialists, Thyme Care helps members understand their diagnosis, proactively manage and address symptoms, and quickly connect them to care. By bringing together oncology providers, primary care physicians, and health plans in its collaborative care delivery model, Thyme Care delivers unwavering support and resources, ensuring informed decisions at every stage of the cancer diagnosis. 

DH 50 MM

CB Insights Digital Health 50 winners were selected from a pool of over 10K companies, including applicants and nominees. They were chosen based on several factors, including CB Insights datasets — covering R&D activity, Mosaic scores, business relationships, software buyer transcripts, investor profiles, news sentiment analysis, competitive landscape, and team strength — along with criteria such as tech novelty, market potential, and impact on the industry

"From bringing clinical trials to underserved populations to developing new drugs and therapies, this year’s Digital Health 50 winners are transforming the future of healthcare,” said Alex Lennox-Miller, CB Insights’ Lead Healthcare Analyst. “We are excited to follow the meaningful impact, industry-leading innovations, and continued success of this year’s winners.” 

About CB Insights

CB Insights builds software that enables the world's best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com.



About Thyme Care 

Thyme Care is the leading value-based care partner, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers, and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with providers, creating a hybrid collaborative care delivery model that guides and supports the entire patient journey. Thyme Care empowers over 300 oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit www.thymecare.com.


Kimberly Dreisinger
Thyme Care Communications


Back to Blog